Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in Ukraine

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: Ukraine Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20082
20091
20102
20112
20131
20163
20181
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S4
AstraZeneca2
Eli Lilly and Company2
Janssen Research & Development, LLC2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Takeda2
AbbVie1
Intra-Cellular Therapies, Inc.1
Sumitomo Pharma America, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder17
Depressive Disorder4
Mood Disorders4
Mental Disorders3
Bipolar Disorder1
Dysthymic Disorder1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.